An adverse drug response (ADR) is a negative or damaging reaction that occurs after taking a medication or medication combination under everyday circumstances and is thought to be caused by the medication. Usually, an ADR calls for stopping the medication or lowering the dose. An adverse reaction is any injury that happens to a patient while they are taking medication, regardless of whether the medication is thought to be the cause or not. Any impact medicine has that is not the intended therapeutic effect—whether positive, negative, or neutral—is considered a side-effect. Although the terms "side-effect" and "ADR" are sometimes used interchangeably, the former generally denotes a less negative, predictable impact that may not even necessitate stopping therapy (e.g., ankle edema with vasodilators.) When a medicine's dosage or plasma concentration exceeds the therapeutic range, whether purposefully or inadvertently, it can lead to undesirable consequences. These unfavourable effects are referred to as drug toxicity (drug overdose). Addiction or dependency, major physiological harm (such as damage to the kidneys, liver, or heart), psychological impairment (abnormal behaviour patterns, hallucinations, memory loss), or even death can result from the misuse of recreational or therapeutic substances.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India